BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 14970058)

  • 1. Expanded screening of newborns for genetic disorders.
    Waisbren SE; Levy HL
    JAMA; 2004 Feb; 291(7):820-1; author reply 821. PubMed ID: 14970058
    [No Abstract]   [Full Text] [Related]  

  • 2. Newborn screening for metabolic disorders.
    Waisbren SE
    JAMA; 2006 Aug; 296(8):993-5. PubMed ID: 16926360
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapid diagnosis of medium chain Acyl Co-A dehydrogenase (MCAD) deficiency in a newborn by liquid chromatography/tandem mass spectrometry.
    la Marca G; Malvagia S; Donati MA; Morrone A; Pasquini E; Zammarchi E
    Rapid Commun Mass Spectrom; 2003; 17(23):2688-92. PubMed ID: 14648909
    [No Abstract]   [Full Text] [Related]  

  • 4. [Expanded newborn screening in the Region of Murcia, Spain. Three-years experience].
    Juan-Fita MJ; Egea-Mellado JM; González-Gallego I; Moya-Quiles MR; Fernández-Sánchez A
    Med Clin (Barc); 2012 Dec; 139(13):566-71. PubMed ID: 22137990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal screening for inborn errors of metabolism.
    Morris AA
    Indian Pediatr; 2000 Dec; 37(12):1303-6. PubMed ID: 11119331
    [No Abstract]   [Full Text] [Related]  

  • 6. Policy issues related to expanded newborn screening: a review of three genetic/metabolic disorders.
    Bishop Hubbard H
    Policy Polit Nurs Pract; 2007 Aug; 8(3):201-9. PubMed ID: 18178927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mass Screening for Inborn Errors of Metabolism].
    Ito T
    Rinsho Byori; 2015 Apr; 63(4):441-9. PubMed ID: 26536777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newborn screening for medium chain acyl-CoA dehydrogenase deficiency: evaluating the effects on outcome.
    Dezateux C
    Eur J Pediatr; 2003 Dec; 162 Suppl 1():S25-8. PubMed ID: 14628139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding newborn screening: process, policy, and priorities.
    Moyer VA; Calonge N; Teutsch SM; Botkin JR;
    Hastings Cent Rep; 2008; 38(3):32-9. PubMed ID: 18581935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzymatic diagnosis of medium-chain acyl-CoA dehydrogenase deficiency by detecting 2-octenoyl-CoA production using high-performance liquid chromatography: a practical confirmatory test for tandem mass spectrometry newborn screening in Japan.
    Tajima G; Sakura N; Yofune H; Nishimura Y; Ono H; Hasegawa Y; Hata I; Kimura M; Yamaguchi S; Shigematsu Y; Kobayashi M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 823(2):122-30. PubMed ID: 16046200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal screening for medium chain acyl-CoA deficiency: high incidence in Lower Saxony (northern Germany).
    Sander S; Janzen N; Janetzky B; Scholl S; Steuerwald U; Schäfer J; Sander J
    Eur J Pediatr; 2001 May; 160(5):318-9. PubMed ID: 11388605
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemical findings in common inborn errors of metabolism.
    Pasquali M; Monsen G; Richardson L; Alston M; Longo N
    Am J Med Genet C Semin Med Genet; 2006 May; 142C(2):64-76. PubMed ID: 16602099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for inherited metabolic disease in newborn infants using tandem mass spectrometry.
    Leonard JV; Dezateux C
    BMJ; 2002 Jan; 324(7328):4-5. PubMed ID: 11777783
    [No Abstract]   [Full Text] [Related]  

  • 14. Medicine. Fast technology drives new world of newborn screening.
    Marshall E
    Science; 2001 Dec; 294(5550):2272-4. PubMed ID: 11743177
    [No Abstract]   [Full Text] [Related]  

  • 15. Newborn screening for medium chain acyl CoA dehydrogenase deficiency.
    Leonard JV; Dezateux C
    Arch Dis Child; 2009 Mar; 94(3):235-8. PubMed ID: 18838415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanded newborn metabolic screening programme in Hong Kong: a three-year journey.
    Chong SC; Law LK; Hui J; Lai CY; Leung TY; Yuen YP
    Hong Kong Med J; 2017 Oct; 23(5):489-96. PubMed ID: 28862145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted metabolomics in the expanded newborn screening for inborn errors of metabolism.
    Scolamiero E; Cozzolino C; Albano L; Ansalone A; Caterino M; Corbo G; di Girolamo MG; Di Stefano C; Durante A; Franzese G; Franzese I; Gallo G; Giliberti P; Ingenito L; Ippolito G; Malamisura B; Mazzeo P; Norma A; Ombrone D; Parenti G; Pellecchia S; Pecce R; Pierucci I; Romanelli R; Rossi A; Siano M; Stoduto T; Villani GR; Andria G; Salvatore F; Frisso G; Ruoppolo M
    Mol Biosyst; 2015 Jun; 11(6):1525-35. PubMed ID: 25689098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanded newborn screening: outcome in screened and unscreened patients at age 6 years.
    Wilcken B; Haas M; Joy P; Wiley V; Bowling F; Carpenter K; Christodoulou J; Cowley D; Ellaway C; Fletcher J; Kirk EP; Lewis B; McGill J; Peters H; Pitt J; Ranieri E; Yaplito-Lee J; Boneh A
    Pediatrics; 2009 Aug; 124(2):e241-8. PubMed ID: 19620191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Screening of newborns for inborn errors of metabolism by tandem mass spectrometry].
    Simonsen H
    Ugeskr Laeger; 2002 Nov; 164(48):5607-12. PubMed ID: 12523003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medium chain acyl coenzyme A dehydrogenase (MCAD) deficiency: the case for screening all newborns.
    Alluri VN; Mulvihill JJ
    J Okla State Med Assoc; 2002 May; 95(5):326-8. PubMed ID: 12043106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.